Transfer RNA cleavages by onconase reveal unusual cleavage sites
Avvaru N Suhasini1, Ravi Sirdeshmukh
1Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad 500 007, India.
Abstract:
Onconase, a protein from amphibian eggs and a homologue of pancreatic ribonuclease (RNase) superfamily, is cytotoxic, exhibits antitumor and antiviral activity, and is in phase III clinical trials. It has been shown to predominantly target cellular tRNA on its entry into mammalian cells (Saxena, S. K., Sirdeshmukh, R., Ardelt, W., Mikulski, S. M., Shogen, K., and Youle, R. J. (2002) J. Biol. Chem. 277, 15142-15146). Cleavage site mapping using natural tRNA substrates, in vitro, revealed predominant cleavage sites at UG and GG residues. Cleavages at UG or the less intense cleavages at CG sites are consistent with the known base specificity of onconase. However, predominance of cleavages at selected G-G bonds is unusual for a homologue of pancreatic RNases. Interestingly, in at least three of the four tRNA substrates studied, the predominant cleavages mapped in the triplet UGG located in the context of the variable loop or the D-arm of the tRNA. The cleavage specificity of onconase observed by us thus indicates another special feature of this enzyme, which may be relevant to its cellular actions.
Insights
Onconase, an antitumor protein, primarily cleaves transfer RNA (tRNA) at specific UG and GG sites within mammalian cells. This unusual G-G bond cleavage, particularly at UGG triplets, highlights a unique feature of onconase
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- Onconase, a protein from amphibian eggs, is a homologue of pancreatic ribonuclease (RNase).
- It exhibits cytotoxic, antitumor, and antiviral activities and is currently in phase III clinical trials.
- Onconase has been shown to predominantly target cellular transfer RNA (tRNA) in mammalian cells.
Purpose of the Study:
- To investigate the specific cleavage sites of onconase on natural tRNA substrates.
- To understand the base specificity and unusual cleavage patterns of onconase.
- To correlate cleavage specificity with onconase's cellular actions.
Main Methods:
- In vitro cleavage site mapping using natural tRNA substrates.
- Analysis of cleavage products to determine predominant cleavage sites.
- Comparison of onconase cleavage specificity with known pancreatic RNase specificities.
Main Results:
- Onconase predominantly cleaved tRNA at UG and GG residues.
- Cleavage at CG sites was observed but less intense.
- Unusually, predominant cleavages occurred at selected G-G bonds, particularly within UGG triplets in the variable loop or D-arm of tRNA substrates.
Conclusions:
- Onconase exhibits a unique cleavage specificity, differing from typical pancreatic RNases, especially regarding G-G bond cleavage.
- The predominant cleavage at UGG triplets in specific tRNA regions represents a special feature of onconase.
- This distinct cleavage specificity may be crucial for onconase's cytotoxic and therapeutic effects in cellular actions.
More Related Videos
09:16Analysis of RNA Processing Reactions Using Cell Free Systems: 3' End Cleavage of Pre-mRNA Substrates in vitro
Published on: May 3, 2014
10:51Fluorescence Based Primer Extension Technique to Determine Transcriptional Starting Points and Cleavage Sites of RNases In Vivo
Published on: October 31, 2014
Related Concept Videos
RNA Splicing
Gene Conversion
RNA Splicing
RNA Editing
Ribozymes
Ribozymes can be...
Restriction Enzymes
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
